Grünenthal is a global leader in pain management and related diseases. As a science-based, privately-owned pharmaceutical company, we have a long track record of bringing innovative treatments and state-of-the-art technologies to patients worldwide. Our purpose is to change lives for the better – and innovation is our passion. We are focusing all of our activities and efforts on moving towards our vision of a world free of pain.
We are present in 29 countries with affiliates in Europe, Latin America and the US.
Our products are sold in more than 100 countries.
4,700 employees work for our group worldwide.